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Background:  The cardiotoxic effects of anthracycline (ANT)-based chemotherapy are well documented. Biomarkers may be useful for 
detection of early cardiotoxicity before changes in left ventricular ejection fraction (LVEF) can be observed.
hypothesis: To determine the predictive values of troponin I (Beckman), high-sensitivity troponin T (hsTnT), N-terminal prohormone B-type 
natriuretic peptide (NT-proBNP) and high-sensitivity C-reactive protein (hsCRP) in predicting cardiotoxicity in patients receiving ANT-based 
chemotherapy.
methods:  This was a prospective cohort study where consecutive patients underwent serial evaluation of cardiac function and biomarkers 
before and at 3, 6 and 12-months following ANT-based chemotherapy. Cardiotoxicity was defined as a reduction of ≥5% from baseline 
LVEF with symptoms of heart failure or an asymptomatic reduction in LVEF of ≥10%.
results:  There were 65 patients with a mean age of 64.5 years and 54% were females. Five patients (7.7%) developed asymptomatic 
cardiotoxicity. Six and 12-month troponin I had the best predictive values (Table 1). Six-month hsCRP was also predictive of cardiotoxicity, 
while the predictive value of 6-month NTproBNP was borderline.
conclusion:  In patients who received ANT-based chemotherapy, troponin I was predictive of early asymptomatic cardiotoxicity.
Table 1:
Baseline
C-statistic (95% CI);
p-value
3-month
C-statistic (95% CI);
p-value
6-month
C-statistic (95% CI);
p-value
12-month
C-statistic (95% CI);
p-value
TnI 0.50(0.20-0.80); p=1.00
0.76
(0.58-0.95);
p=0.15
0.87
(0.71-1.00); p=0.04
0.88
(0.74-1.00); p=0.03
hsTnT
0.52
(0.19-0.86)
p=0.90
0.68
(0.36-0.99); p=0.32
0.68
(0.35-1.00)
p=0.30
0.62
(0.31-0.94); p=0.49
hsCRP 0.61(0.25-0.96); p=0.55
0.61
(0.26-0.96); p=0.55
0.88
(0.76-1.00); p=0.03
0.64
(0.25-1.00); p=0.43
NT-proBNP 0.34(0.00-0.70); p=0.38
0.55
(0.14-0.93); p=0.85
0.81
(0.51-1.00); p=0.09
0.33
(0.00-0.87); p=0.35
